Actualités

CVS Health (CVS) has received quite a bit of attention from Zacks.com users lately. Therefore, it is wise to be aware of the facts that can impact the stock's prospects.

While analysts acknowledged incoming finance chief David Denton’s credentials, they also flagged his lack of activewear experience.

David Denton, who has led Pfizer's finances since 2022, will take over as Nike's chief financial officer on Aug. 17

Nike names David Denton, a former Pfizer and CVS Health executive, as its next chief financial officer, and provides updated guidance.

The investigation by Florida’s attorney general comes as states look to check pharmacy benefit managers for allegedly driving up drug costs.

Nike announced a CFO transition and said fourth-quarter results remain on track, excluding a one-time tariff refund benefit.

Florida’s attorney general says he is examining whether CVS’s pharmacy benefit manager steers patients to its own pharmacies.

CVS Health Corporation (NYSE:CVS) is one of the 10 Cheap Jim Cramer Stocks to Invest In Right Now. The New York Times, in an article published on June 11, 2026, pointed to two federal reports from the Department of Health and Human Services and stated that CVS Health Corporation (NYSE:CVS) and other major Medicare Advantage […]

It's expanding its scope of services for GLP-1 obesity medications.

Clover Health Investments, Corp. (NASDAQ:CLOV) was among the stocks on Jim Cramer’s radar on Mad Money, as he advised investors to care about where a stock is going, not where it has been. A caller referenced Cramer’s previous comment, calling it speculative, and noted that the company reported GAAP profitability in Q1 2026 and guided […]

Does CVS Health (CVS) have what it takes to be a top stock pick for momentum investors? Let's find out.

CVS Health is rolling out a first of its kind aluminum bottle for store branded over the counter products across its national pharmacy network. The company is also funding mobile maternal health clinics in underserved rural areas of Missouri, focused on prenatal and mental health services. These moves expand CVS Health’s sustainability and community health efforts beyond its core retail and insurance operations. For investors watching NYSE:CVS, these announcements add context around how the...

Former CEOs of Humana and CVS Health have been appointed as advisors to Optura, an AI focused healthcare startup. UnitedHealth Group (NYSE:UNH) is participating on the advisory side, aligning with efforts to measure and optimize return on AI investment in healthcare. The collaboration brings together major US health insurers and service providers around a shared AI platform approach. For UnitedHealth Group, a large diversified health insurer and services company, this move puts more focus...

Earnings results often indicate what direction a company will take in the months ahead. With Q1 behind us, let’s have a look at CVS Health (NYSE:CVS) and its peers.

TD Cowen analysts estimate that the total addressable market for longevity healthcare exceeds $250 billion.

Dave Denton will leave in August as Pfizer works through its post-COVID reset.

Long before the stock surged, the company had been openly broadcasting its decision to choose profit over scale. The market initially ignored the signal - until the turnaround became undeniable.

Express Scripts and the PBM lobby are following in CVS Caremark’s footsteps in filing complaints challenging the FAIR Rx Act, which was passed earlier this year despite vehement opposition from PBMs.

It's not too late to jump on the bandwagon.

Don't underestimate the potential upside for this diversified healthcare stock.

STNE, USNA, STRA, NEXA and CVS are highlighted as low price-to-book stocks with solid growth projections and strong value scores.

CVS Health Corporation (NYSE:CVS) is included among Billionaire Larry Robbins’ 10 Dividend Stock Picks. On June 4, Morgan Stanley raised its price recommendation on CVS Health Corporation (NYSE:CVS) to $111 from $106. It reiterated an Overweight rating on the shares. The analyst noted that managed care stocks have been “grinding higher” as signs of softer […]

The HHS Office of Inspector General highlights CVS Health's Medicare Advantage arm for high denial rates in post acute care, raising questions about senior access to services. CVS Health advances its primary care partnership with Mass General Brigham after clearing a key regulatory hurdle. Both developments focus attention on NYSE:CVS and its approach to care delivery, costs, and regulatory oversight. These updates arrive while CVS Health, trading at $101.96, has seen the stock up 6.3% over...

With an annual dividend yield of 2.65%, CVS Health Corporation (NYSE:CVS) is included among the 12 High Yield Fortune 500 Stocks to Buy Now. America’s leading health solutions company, CVS Health Corporation (NYSE:CVS), provides advanced health care from pharmacy services and health plans to health and wellness. On June 8, Mizuho upped its price target on […]

When Rite Aid, a major pharmacy retailer, filed for Chapter 11 bankruptcy a second time in 2025, it led to the shuttering of its 1,250 locations. Over time, many were sold to competitors like CVS and Walgreens, and some spaces were taken up by retailers such as Kroger and Albertsons. But some ...

Healthcare has spent 2026 on the sidelines while the rest of the market does the heavy lifting. The Health Care Select Sector SPDR Fund (NYSEARCA:XLV) is down around 1% year to date even after a 6% one-month bounce. That stagnation has left a handful of high-margin operators trading at forward multiples that look out of ... 3 Ridiculously Cheap Healthcare Stocks to Buy in June

Molina Healthcare secures an Illinois Medicaid managed care contract starting in 2027, reinforcing its position in a key market and supporting long-term growth.

Here’s a 30,000-foot view on practical ways to protect your investing capital and gain a real edge over the house in a stock market designed to keep you glued to the slots instead of growing your wealth.

The tentative deal comes months after CVS Health reached a proposed settlement in the lawsuit alleging major pharmacy benefit managers are inflating insulin costs.

Over the past six months, CVS Health has been a great trade, beating the S&P 500 by 20%. Its stock price has climbed to $100.39, representing a healthy 26.4% increase. This was partly thanks to its solid quarterly results, and the run-up might have investors contemplating their next move.